Judges are considering consolidating Actos lawsuits that have already been filed against the drug’s manufacturer to a federal court. Lawyers involved in these cases have predicted that as many as 10,000 lawsuits could eventually be filed against Takeda Pharmaceuticals by patients who developed bladder cancer after taking the diabetes drug.
Takeda is allegedly facing dozens of lawsuits alleging that it failed to properly warn consumers that. Actos could lead to an increased risk of bladder cancer if taken for longer than one year. The company is currently facing at least 54 lawsuits over Actos.
Actos became the most widely-prescribed type II diabetes medication in the world after a similar medication known as Avandia was recalled due to an increased risk of heart attacks and strokes. Actos was later withdrawn by regulators in France and Germany due to its link to an increased bladder cancer risk.